Skip to main content
Equibles
IDYA logo

IDYA · IDEAYA Biosciences, Inc. · Metrics

Track IDYA — free

Use IDYA with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research IDYA.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$35.36 +1.55 (+4.58%) At close · Oct 20
Russell 2000 member Rebalance outlook locked
Market Cap
$3.41B
Shares
96.49M
Volume · Oct 20 962.27K Avg daily vol (3M) 789.06K

IDYA metrics

76 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$35.36
Market cap
$3.41B

Price action

20 metrics
Price change (1W)
+3.2%
Price change (30D)
-9.0%
Price change (3M)
-1.8%
Price change (6M)
+11.1%
Price change (YTD)
+2.3%
Price change (1Y)
+15.9%
Trailing year
Price change (5Y)
+56.7%
52-week high
$42.48
52-week low
$27.60
Change from 52-week high
-16.8%
Change from 52-week low
+28.1%
Annualized volatility
45.6%
Annualized volatility (3M)
35.8%
Beta
1.0
RSI (14D)
45.0
Price vs SMA 50
-6.5%
Price vs SMA 200
+3.6%
Avg volume (3M)
789,057
Relative volume
1.2
Average dollar volume
$29.52M

Company

3 metrics
Sector
Healthcare
Industry
Biotechnology
Shares outstanding
96.49M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
—
P / book
2.8
reciprocal yield 35.1%
FCF yield
-3.3%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-5.1%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
116.7×
reciprocal yield 0.9%
EV / revenue historical average (5Y)
91.3×
reciprocal yield 1.1%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2024-11-04

Profitability

9 metrics
Gross margin
—
Operating margin
-72.8%
Trailing 12 months
Net margin
-52.0%
Gross profit (TTM)
—
Operating profit (TTM)
−$216.95M
Net income (TTM)
−$175.02M
Trailing 12 months
Diluted EPS (TTM)
$-1.91
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
$-2.42
EBITDA per diluted share (TTM)
$-2.39
Net income per diluted share (TTM)
$-1.96
Operating cash flow per diluted share (TTM)
$-1.26
Free cash flow per diluted share (TTM)
$-1.28
Capital expenditures per diluted share (TTM)
$0.02
R&D per diluted share (TTM)
$4.18
Stock compensation per diluted share (TTM)
$0.62
Book value per share
$11.65

Growth

11 metrics
Revenue growth YoY
+3,024.4%
Year over year
Net income growth YoY
—
Revenue (TTM)
—
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+4.1%
Year over year · more shares
Revenue CAGR (3Y)
+62.5%
Revenue CAGR (5Y)
+62.1%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-14.6%
Return on assets
-13.4%
Debt / equity
0.0
Current ratio
10.5
EBITDA (TTM)
−$214.16M
Free cash flow (TTM)
−$113.87M
Quick ratio
10.5
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$828.96M
Latest balance sheet
Cash & equivalents
$272.59M
Total assets
$1.31B
Total debt
$0

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$111.66M
Capital expenditures (TTM)
$2.21M
R&D (TTM)
$374.01M
SG&A (TTM)
—
Stock compensation (TTM)
$55.20M
R&D / revenue
—
Stock compensation / revenue
—

Ownership (13F)

9 metrics
13F filers
287
13F filer change QoQ
+30
Institutional ownership
106.7%
Conviction holders (share of 13F filers)
1.8%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
+8.7%
Holder tenure
14.2
Price vs estimated holder cost
+25.9%

Ownership (registered funds)

1 metrics
Index-fund ownership
15.9%

Short interest

3 metrics
Short interest
9.5%
Latest settlement · 8.4 days to cover
Days to cover
8.4d
Short-squeeze score
71 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$985,397
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1676725 CUSIP 45166A102 13F (30d) 25 filings 25 filers Visit website Investor relations